Quilter Plc Has $57.62 Million Position in Zoetis Inc. (NYSE:ZTS)

Quilter Plc boosted its stake in Zoetis Inc. (NYSE:ZTS) by 17.9% during the 4th quarter, HoldingsChannel.com reports. The fund owned 353,674 shares of the company’s stock after acquiring an additional 53,596 shares during the period. Zoetis accounts for 1.1% of Quilter Plc’s portfolio, making the stock its 29th biggest position. Quilter Plc’s holdings in Zoetis were worth $57,624,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in ZTS. Pensionfund Sabic boosted its holdings in shares of Zoetis by 55.6% during the 4th quarter. Pensionfund Sabic now owns 11,200 shares of the company’s stock worth $1,825,000 after buying an additional 4,000 shares in the last quarter. PFW Advisors LLC bought a new position in shares of Zoetis in the 4th quarter worth $1,764,000. JPMorgan Chase & Co. lifted its holdings in shares of Zoetis by 10.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 2,916,539 shares of the company’s stock worth $569,834,000 after purchasing an additional 279,092 shares in the last quarter. Simplify Asset Management Inc. bought a new position in shares of Zoetis in the 3rd quarter worth $11,684,000. Finally, Nordea Investment Management AB lifted its holdings in shares of Zoetis by 38.3% in the 4th quarter. Nordea Investment Management AB now owns 2,065,514 shares of the company’s stock worth $336,266,000 after purchasing an additional 572,511 shares in the last quarter. 92.80% of the stock is currently owned by institutional investors.

Zoetis Trading Down 1.6 %

Zoetis stock opened at $171.37 on Monday. The company has a current ratio of 3.69, a quick ratio of 2.27 and a debt-to-equity ratio of 1.26. The business’s fifty day simple moving average is $169.26 and its two-hundred day simple moving average is $179.22. Zoetis Inc. has a 12 month low of $144.80 and a 12 month high of $200.53. The company has a market capitalization of $77.32 billion, a price-to-earnings ratio of 32.21, a price-to-earnings-growth ratio of 2.77 and a beta of 0.90.

Zoetis Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 3rd. Shareholders of record on Monday, April 21st will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.17%. The ex-dividend date is Monday, April 21st. Zoetis’s dividend payout ratio (DPR) is 37.59%.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the company. Stifel Nicolaus lowered their price target on Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a research report on Tuesday, January 7th. Leerink Partners assumed coverage on Zoetis in a research report on Monday, December 2nd. They set an “outperform” rating and a $215.00 target price for the company. Morgan Stanley cut their target price on Zoetis from $248.00 to $243.00 and set an “overweight” rating for the company in a research note on Wednesday, January 29th. UBS Group began coverage on Zoetis in a report on Monday, December 9th. They set a “neutral” rating and a $196.00 price objective on the stock. Finally, Leerink Partnrs raised Zoetis to a “strong-buy” rating in a research note on Monday, December 2nd. One investment analyst has rated the stock with a hold rating, ten have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $215.00.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.